Liver Disease Treatment Market To Get Rise By Top International Players [Gilead Science, Bayer AG, AstraZeneca, GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, F. Hoffmann-La Roche AG, Novartis AG & Johnson &Johnson, Others]

Global Liver Disease Treatment Market is expected to garner $19,536 million by 2022, registering a CAGR of 11.72% during the forecast period 2016 - 2022. Liver disease comprises of wide range of complex conditions affecting the liver. Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/388

The antiviral drug segment held major share of the total market in 2015 and is expected to maintain its lead throughout the forecast period. This is attributed to the high incidences of virus infected liver diseases including Hepatitis. However, corticosteroid drug segment registered fastest growing segment during the forecast period.

The factors driving the liver disease treatment market are rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets; and increasing prevalence of liver diseases. In addition, growing geriatric population, increasing government and non-government awareness programs, and rising R&D investments for the development of novel therapies are also playing pivotal role in the growth of the liver disease treatment market. Moreover, owning to the patent expiry of several drugs such as Epivir- HBV, generic and biosimilar drugs market have more potential in the liver disease treatment arena. However, stringent government regulations for the approval of drugs, high cost incurred in R&D and risks of side-effects associated with liver disease medications is expected to hamper the growth of the market during the forecast period.

North America and Europe collectively accounted for more than two-fourth of the total liver disease treatment market in 2015, and are expected to maintain their position throughout the forecast period. This is due to the increasing prevalence of liver diseases, growing geriatric population, and increased awareness about the various liver diseases and their treatment in these regions. In addition, advancement in R&D is anticipated in the development of novel drug therapy for the treatment of liver diseases.

The prompt players in the liver disease treatment market have adopted strategies such as innovative product launch, merger & acquisition, partnership and business expansion to gain maximum market share. The major companies profiled in the report include,

- Gilead Science Inc.,
- Bayer AG,
- AstraZeneca PLC,
- GlaxoSmithKline plc,
- Merck & Co. Inc,
- Sanofi AG ,
- Pfizer Inc.,
- Bristol-Myers Squibb Company,
- Novartis AG, and
- Johnson & Johnson Private Limited.

Key findings of liver Disease Treatment Market:

- Corticosteroids drug is projected to be the fastest growing segment, registering a CAGR of 16.49% during the forecast period
- North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022
- Asia-Pacific is expected to grow with a CAGR of around 12.51%, due to increasing prevalence of liver diseases and increasing R&D investments in this region

Get Customized Report as Required @ https://www.alliedmarketresearch.com/request-for-customization/388

Table Of Content


Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key Findings

3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.3.3 Top investment pockets

3.3 Porters five forces analysis

3.3.1 Low bargaining power of suppliers due to large number of suppliers and low switching cost
3.3.2 Moderate bargaining power of buyer due to large number of buyer, high product dependency and less switching cost.
3.3.3 Low threat of substitutes due to low preference of substitutes and high brand loyalty
3.3.4 Low threat of new entrants due to presence of dominant players and strict government regulations
3.3.5 Presence of numerous players, high exist barriers, high economic base increases the competition among rivalries

3.4 Market share analysis, 2015
3.5 Drivers

3.5.1 Rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets
3.5.2 Increasing prevalence of liver diseases
3.5.3 Growing geriatric population
3.5.4 Increasing government and non-government awareness programs
3.5.5 Increasing R&D investments for the development of novel therapies

3.6 Restraint

3.6.1 Stringent government regulations
3.6.2 High cost incurred in drug R&D
3.6.3 Side effect associated with medication

3.7 Opportunities

3.7.1 Availability of generic and bio-similar drugs

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/liver-diseases-therapeutics-market.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.